Daily Archives: March 23, 2007

US Stock Market Wrap (MAR 23, 2007)

DJIA                    12,481.01; Up 19.87 (0.16%)
NASDAQ            2,456.18; Up 4.44 (0.18%)
S&P500              1,436.11; Up 1.57 (0.11%)
10YR-Bond        4.613%; Up 0.024
NYSE Volume    2,606,201,000
NASD Volume    1,615,797,000

CMGI (CMGI) traded over 51 million shares as small cap cult stock traders just can’t get enough of this one.  +0.9% to $2.20.

Amgen (AMGN) and Genentech (DNA) hammered; AMGN stopped a drug trial and DNA hit over the coming quarter guidance.  Imclone (IMCL) traded up big after the Amgen dropped trial as they compete.  AMGN -4% to $58.02; DNA -3/2% to $82.56; IMCL +13% to $38.50.

Dendreon (DNDN) traded up big again on much stronger volume ahead of next week’s FDA review. +13% to $4.47; options active.

Omnivision (OVTI) traded up after TheStreet.com noted that Eastman Kodak (EK) may be interested in acquiring it. +10.6% to $13.35.

China YouTV (CYTV) gave back lots after more skeptics emerged.  I received many notes and have seen many notes saying they were a scam.  I was very cautious on this one yesterday because of the name, the OTC, the 300% gain, and the fact that it was started for basically $130,000 in China this March in a joint-venture. -33% to $1.49.

Palm (PALM) managed to close up on lackluster earnings numbers (slightly ahead) even though there was no merger as had been hoped.  Go figure.  +2% to $18.10.

Vonage (VG) fell sharply after the company had a permanent injunction ruling against it in the Verizon case.  VG -25.9% to $3.00 on 9.8 million shares.

Kraft (KFT) rose on being added to the S&P 500 Index.  +0.45% to $32.00 on 10.4 million shares.

Jabil (JBL) traded down on its earnings guidance under estimates. JBL -10.7% to $22.26.

Orient Express (OEH) traded up as it has been a takeover rumor this week. +3.4% to $60.60.

Hana Bio (HNAB) fell sharply on a resubmission to the FDA.  -35% to $2.41.

Glu Mobile (GLUU) fell a day after its IPO, traders are skeptical as everything is licensed. -6% to $11.51.

Jon C. Ogg
March 23, 2007

Jon Ogg can be reached at jonogg@247wallst.com; he does not own securities in the companies he covers.

Cramer’s Break-Up Plays

On today’s STOP TRADING on CNBC, Cramer also said he thought the ads against Wal-Mart (WMT) on the terrorism link were too much.

On Vonage (VG), after the ruling went against the company and it was down 22%, Cramer said that they should keep their mouth shut and not issue press releases claiming what they expect to happen. 

Cramer has some hidden value plays.  He looked around at others: ConAgra (CAG) and Clorox (CLX) could both easily break-up.  He also thinks that railroads could be Union Pacific (UNP), Norfolk Southern (NSC), and CSX (CSX) could all break up and they are all pro-shareholder.

Global ETFs Overbought

This is an interesting post from one of our contributors.  If the bulk of these overseas markets are in overbought territory again, then any excuse the markets can use to sell off may be taken advantage of.  Of course the flip side and the balanced side would dictate that readings like that can go on and on…… Here goes:

What a difference a week makes.  Asshown by our overbought/oversold charts of global ETFs below, almostall countries that we track are currently at overbought levels onceagain.

Gletf323

Oboskey

Posted by Ticker Sense
http://tickersense.typepad.com/

Cramer Took the Pepsi Challenge

On today’s WALL STREET CONFIDENTIAL video on TheStreet.com, Jim Cramer discussed going to the Pepsi (PEP) plant of the healthy snacks for Frito-Lay.  Cramer said he was critical of the Frito-Lay unit, but he went to see their healthy snacks factory and was impressed.  He was struck about a new line of vegetable sticks and more, and the sales are starting to accelerate.  Cramer thinks it will boost the revenue growth and he’s changing his stance and he’s going positive in Pepsi (PEP) as a result.

After looking at the charts, Pepsi (PEP) is up about 7% in the last year while Coca-Cola (KO) is up about 12%; PEP is up about 1% in the last 3 months while KO is down about 1% in the same time.  PEP trades at $63.93, toward the higher end of the $56.51 to $65.99 52-week trading range (and close to all-time highs). 

Jon C. Ogg
March 23, 2007

Vonage = Slippage

Vonage (VG) already went from bad to worse, and today went to even FAR WORSE.  This was already one of the worst IPO’s in recent history.  Now it is not even possible to calculate the exact impact.  A federal judge issued a permanent injunction Friday that prevents Vonage from using key internet telephony technology rights owned by Verizon Communications (VZ).

The granted request to Verizon’s injuction prohibits Vonage from using some if the VoIP technologies that make their telephone calls work.  This one is not over yet, but there is probably going to be a lot more pain felt by shareholders.

Shares of Vonage were halted at 12:13:46 today, but it looks like the shares fell 6% more to $3.799 before the halt was enacted; no resumption time has been set.  This looks like it is going from ugly to fugly, and now there are questions of how Vonage will survive.  The company might not be able to afford the royalties that Verizon will demand, and if so then customers around the country will probably have to worry about getting new service installed elsewhere.

What would Homer say? Doh!

Jon C. Ogg
March 23, 2007

Wal-Mart: New Criticism Gone Too Far?

Before reading some non-stock and non-equity information, there of course is some stock-related data for you at the end of this article.

After doing some routine outlying web searches this morning I saw a "new" video located on Yahoo! Finance that w as run by Fox Business News online called "Wal-Mart Helping Terrorist? WMT" and I knew this was going to get some attention (even if it is yesterday’s news).  It also feels like re-sensationalizing the flip side of something sensationalized over and over, but that’s another story.  This was also something that was picked up yesterday by CNN and you can check that too. 

The video discusses the activist group "Wake Up Wal-Mart," and you can verify all of this for yourself on the activist website, running television ads this week in 16 major cities titled "America’s risk."  The ads are using terrorism scare as an attack against Wal-Mart and its opposition of scanning inbound cargo containers at US ports.  The ad shows an image of a nuclear explosion (not a nukular one), an image of Osama bin Laden, and footage of terrorist camps.  You can see the video

Screening every single cargo container is probably a very costly proposition and if you have ever seen how government regulation of something to this tune is implemented you will know it is great in theory and will probably fall far short in reality.  I am personally for cargo containers being screened, but I am also aware of the fact that this is above and beyond a major feat and regardless of what the regulations mandate there is a precedent of the results falling one-hundred miles short of the goals.

Wal-Mart is probably going to be for anything that speeds up deliveries and at the cheapest cost possible.  Screening ‘every’ cargo container will definitely slow things down and increase transportation costs.  But, trying to use terrorism photos and video footage and showing a nuclear bomb and terrorist camps in an ad campaign against even a company like Wal-Mart?  I have been very vocal against Wal-Mart myself because of its stock performance, and I have noted that Lee Scott could actually reward his shareholders if he left the company.  But this sort of attack looks like it goes too far. 

There is a stock angle to this of course.  BUT….Keep in mind that this is not a New investable trend in global port security and homeland security.  In fact, this has been an investable event since 2004 and ever farther back than that.  These are some of the stocks that might get attention if the interest in this is re-kindled (yes, it has been around before):

L-3 (LLL-NYSE) is a diversified defense player, but they have shipping cargo scanning abilities.  Varian Medical Systems (VAR-NYSE) is mostly known for its medical products, but it has a cargo screening technology that scans cargo for weapons and other contraband.  OSI Systems (OSIS-NASDAQ), via its Rapiscan unit allows cargo screening.  It needs to be pointed out that Rapiscan is mainly in Trucking cargo per its descriptions, but you can imagine the retooling that it could do for rail and/or shipping cargo containers.  There may be others in the field, and there are likely a whole host of OTC or foreign companies that have ambitions and claims in the field.  These are just some of the more established companies that could still see a boost to their business and that have enough other operations that ‘may’ offer a little more stability.

I didn’t think I would be coming to the defense of a company that I feel is so far out of alignment with its shareholders and out of alignment with its customers, but sometimes you see something that has gone too far.

Jon C. Ogg
March 23, 2007

Jon Ogg can be reached at jonogg@247wallst.com; he does not own securities in the companies he covers.

Dendreon Interest Remains; Volume Already Beat Average Day

Dendreon (DNDN-NASDAQ) is still getting plenty of trader attention this morning.  It is going to post significantly higher volume than normal today as the chat rooms and message boards are filling up with more and more data on the FDA panel review next week for its prostate cancer vaccine called Provenge.  Shares were up 10% at $4.36 on last look and that is after a $0.25 gain yesterday to $3.95.  Its 52-week low is only $3.57 and 52-week high is $5.77.  It has already crossed more shares in the first 30+ minutes this morning compared to an average daily volume.

Here is our article from yesterday.  Outsiders are also pointing to an article out of TheStreet.com pointing to significantly higher values if they receive FDA approval (although they did some figure corrections later).  CNBC’s Mike Huckman also ran a blog post on it late yesterday.

This one is going to be one of the more active stocks on an otherwise fairly quiet Friday.  Stock options are perhaps one of the most perceptive methods to see what the market is bracing for.  Right after the open of options today the MAY07 $5.00 CALLS were trading at $1.30, so that stock would have to go up to $6.30 for a new Call option buyer to make any money as of now and that is before any transaction costs. 

Jon C. Ogg
March 23, 2007

Jon Ogg can be reached at jonogg@247wallst.com; he does not own securities in the companies he covers.

Pre-Market Stock News (MAR 23, 2007)

(ABN) ABN AMRO may now get Citigroup joining the bidding process rather than just Barclays.
(AMGN) Amgen fell another 4% to a year low after haling Vectibix trials.
(BEAV) BE Aerospace priced 10.5 million shares of common stock at $32.00, higher than the 9 million shares originally indicated.
(C’) Citigroup’s Chuck Prince being pressured by insiders to buy ABN AMRO; Citi bought 19.9% stake in Indian brokerage firm.
(CFC) Countrywide CEO told Cramer they would win in subprime area and that they were not going to be wiped out all on a CEO interview on Mad Money.
(DCX) Daimler Chrysler up another $2.00 on faster hopes for a Chrysler sale, even though the company says no news until April meeting.
(DNA) Genentech reaffirms its earnings guidance but expects first quarter revenues to be flat to Q4 2006; sees 20 new drugs in 2007-2008 but now sees more than 30 in total from 2007-2010 period.
(DNDN) Dendreon has a prostate cancer drug review at FDA next week.
(FCX) Freeport-McMoRan Copper & Gold has 41 million share common stock and 25 million convertible offering.
(GE) GE buying Sanyo unit in Japan for $1.1 Billion.
(HNAB) Hana Biosciences provides pipeline update for Marqibo Phase 2 relapsed ALL to commence.
(IMCL) Imclone trading up 14% after Amgen trial halted.
(JBL) Jabil indicated lower on forecasts under street estimates.
(KFT) Kraft is added to the S&P 500 Index to replace Sabre-TSG.
(NKE) Nike traded up slightly after beating earnings, but ended up lower on weaker margin forecasts.
(NVD) Novadel’s European formulation of Ondansetron targeted for U.S. Zensana.
(OPWV) Openwave guides earnings and revenues down; appointed new CEO effective immediately; hired Merrill Lynch to explore strategic alternatives; up 6% on hopes of buyout.
(PALM) Palm trading down less than 1% on earnings; no buyout.
(PXR) Paxar trading up 25% or more on a $30.50 buyout from Avery Dennison.
(XMSR) XM Radio was sued by members of the National Music Publishers Association because its sell receivers that allow listeners to store songs.

Jon C. Ogg
March 23, 2007

Jon Ogg can be reached at jonogg@247wallst.com; he does not own securities in the companies he covers.

Full Research Summary (MAR 23, 2007)

ATVI started as Buy at AGEdwards.
AQNT started as Outperform at Credit Suisse.
BOW raised to Overweight at Prudential.
CLC raised to Outperform at Baird.
CPS  started as Mkt Perform at Morgan Keegan.
CVG started as Hold at Stifel Nicolaus.
DOM raised to Hold at AGEdwards.
DWA raised to Buy at Goldman Sachs.
EMC raised to Overweight at JPMorgan.
ERTS started as Buy at AGEdwards.
FD started as Mkt Weight at Thomas Weisel.
FDS started as Neutral at B of A.
FORM cut to Mkt Perform at FBR.
GME started as Hold at AGEdwards.
IGT raised to Neutral at Prudential.
IMCL raised to Overweight at HSBC.
JBL cut to Sector Perform at CIBC, cut to Peer Perform at Bear Stearns.
JCP started as Mkt Weight at Thomas Weisel.
MCS raised to Outperform at Baird.
MIR raised to Buy at B of A.
MLNX started as Neutral at Credit Suisse.
MWY started as Hold at AGEdwards.
NTAP raised to Overweight at JPMorgan.
NOC raised to Mkt Perform at Wachovia.
PALM cut to Reduce at UBS, cut to neutral at BofA.
PEG raised to Buy at B of A.
PGR raised to Mkt Perform at FBR.
POM raised to Buy at B of A.
RRI cut to Sell at B of A.
STP cut to Neutral at Goldman Sachs.
STT raised to Buy at UBS.
THQI started as Buy at AGEdwards.
TRGL cut to Hold at Jefferies.
TTEC started as Buy at Stifel Nicolaus.
TTWO started as Hold at AGEdwards.
URBN raised to Outperform at Wachovia.
WU raised to Buy at AGEdwards.
XTXI raised to Buy at Goldman Sachs.

Jon C. Ogg
March 23, 2007

Jon Ogg can be reached at jonogg@247wallst.com; he does not own securities in the companies he covers.

Will a Buyer Save Openwave From More & More Bad News?

How do you stave off horriffic news?  Announce you are for sale.

Openwave (OPWV) is not a name that has been without controversy, and its shares are up almost 6% at $9.40 pre-market since it is exploring a sale of the company.  It is a former high-flyer that turned into Icarus after earnings warnings and options backdating charges.  The company is replacing David Peterschmidt with Robert Vrij as President & CEO effective immediately.  The company has lowered guidance, which it blames on a product transition: revenues for the quarter are now expected to be $65-70 million versus estimates of $87.5 million.  The company has been delivered with 4 million shares in its buyback plan as part of its $100 million it paid to Merrill Lynch for the total plan.

The company has hired Merrill Lynch to enhance shareholder value, including a possible sale of the company.  Maybe someone else can garner value where the company hasn’t.  The long and short of the matter is that the company has some extremely valuable mobile communications service offerings that would make it an ideal portfolio company.  The flip side is that if you look at the number of mobile players in the space you will realize instantly that the pool of carrier-class customers has been shrinking steadily.

This is one we have wanted to add to the BAIT SHOP for takeover candidates in the past on numerous occasions, but the valuations and shrinking customer pool were always insurmountable factors to ever taking it any higher than a watch list.

The one company that we do think could snap this up and instantly have all of the affiliate and clkient relationships on a wider base is Google (GOOG).  The problem is that now Google may be doing its own phone.  Will it or won’t it?  If not there are probably about 12 other companies that could be interested.  For a private equity firm to want it, the company would most likely need to be profitable and this one is now back in the red.

Jon C. Ogg
March 23, 2007

Jon Ogg can be reached at jonogg@247wallst.com; he does not own securities in the companies he covers.

Goldman Sachs Research Summary (MAR 23, 2007)

Coldwater Creek (CWTR) raised to Buy from Neutral.
Crosstex Energy (XTXI) raised to Buy from Neutral.
Urban Outfitters (URBN) raised to Buy from Neutral.
DreamWorks Animation (DWA) raised to Buy from Neutral.
Polo Ralph Lauren (RL) raised to Buy from Neutral.
Great Plains Energy (GXP raised to Neutral from Sell.

Liz Claiborne (LIZ) downgraded from Buy to Neutral.
Atmos Energy (ATO) downgraded from Neutral to Sell.

Borders (BGP) started as Neutral.
Brown-Forman (BF-B) started as Neutral.

Goldman Sachs reiterated its Conviction Buy List on Coach (COH) and maintained Buy ratings on A&F (ANF), Aeropostale (ARO), and Nike (NKE).

Earlybird Analyst Calls (MAR 23, 2007)

ATVI started as Buy at AGEdwards.
AQNT started as Outperform at Credit Suisse.
CLC raised to Outperform at Baird.
CPS  started as Mkt Perform at Morgan Keegan.
CVG started as Hold at Stifel Nicolaus.
DWA raised to Buy at Goldman Sachs.
EMC raised to Overweight at JPMorgan.
ERTS started as Buy at AGEdwards.
FD started as Mkt Weight at Thomas Weisel.
FDS started as Neutral at B of A.
GME started as Hold at AGEdwards.
JBL cut to Sector Perform at CIBC.
JCP started as Mkt Weight at Thomas Weisel.
MCS raised to Outperform at Baird.
MIR raised to Buy at B of A.
MLNX started as Neutral at Credit Suisse.
MWY started as Hold at AGEdwards.
NTAP raised to Overweight at JPMorgan.
NOC raised to Mkt Perform at Wachovia.
PALM cut to Reduce at UBS.
PEG raised to Buy at B of A.
PGR raised to Mkt Perform at FBR.
POM raised to Buy at B of A.
RRI cut to Sell at B of A.
STT raised to Buy at UBS.
THQI started as Buy at AGEdwards.
TRGL cut to Hold at Jefferies.
TTEC started as Buy at Stifel Nicolaus.
TTWO started as Hold at AGEdwards.
URBN raised to Outperform at Wachovia.
XTXI raised to Buy at Goldman Sachs.

Jon C. Ogg
March 23, 2007

Jon Ogg can be reached at jonogg@247wallst.com; he does not own securities in the companies he covers.

Can Amgen Get the Gorilla Off Its Neck?

Shares of biotech giant Amgen (AMGN) fell another 4% last night after the company announced more negative news.  The company is abandoning a clinical trial of Vectibix, its "was-promising" colon cancer treatment.  An interim look at the trial found that colon cancer patients treated only with chemotherapy and Avastin from Genentech (DNA) were actually more likely to live longer than patients who also received Vectibix.

Yesterday shares closed at $60.47 and have traded as low as $59.00 this year; unfortunately it looks like shares were at $57.85 in after-hours trading on active volume.  Looks like it may be another yearly low.

Shareholders might be taking issue with this proxy filing that showed the CEO pay package: Kevin Sharer received a total pay package of $18.6 million; $1.5 million was his salary, with $4.5 million in bonuses (over meeting short-term and long-term objectives), stock options that are valued somewhere around $11.6 million on the grant date, and $1 million in perks (jet, driver, planning).  Amgen fell from $78.86 at the end of 2005 to $68.31 at the end of 2006.  We have previously noted that the market is treating this one like a plain jane Big Pharma drug stock more than a biotech stock. 

This one has been under fire on capitol hill over its prices charged to Medicare over anemia drugs Epogen and Aranesp, plus new warning labels and FDA reviews over side effects.  It also has some patent issues that may come under more attack, and this has analysts trying to figure out how to model 2008 and 2009 earnings.

Jon C. Ogg
March 23, 2007

Jon Ogg can be reached at jonogg@247wallst.com; he does not own securities in the companies he covers.

Shorts Exit Home Depot

The shorts piled out of Home Deport (HD) in March, dropping short interest 36 million shares from a total of 72 million in February. The interest was cut in half.

HD is actually down slightly this year, about 4%. But, the company has talked about selling its wholesale division, and there are still rumors that private equity will try to buy the entire company. With a market cap of $78 billion, that would have seemed unlikely, but with the Carlyle Group raising $15 billion for its new fund, the idea may not be so far-fetched.

Home Depot also remains committed to its plan to put banking operations in its stores. Positive news on that front could help the stock.

And, finally, there is always talk about a recovery in housing, believeable or not.

Douglas A. McIntyre

Citigroup & ABN AMRO? The Chuck Prince Conundrum

There are multiple reports that Citigroup (C-NYSE) may have a faction inside the company pushing Chuck Prince to jump into the bidding process for ABN AMRO (ABN-NYSE/ADR).  This would be to nudge out Barclays (BCS-NYSE/ADR), or maybe Citigroup would just go after a part of the company.  Back in February we ran a list of companies that were actually large enough to go after ABN AMRO (ABN).  It is somewhat surprising that Bank of America (BAC-NYSE) has been left out here, as this would give them a much wider international footprint and would not cause any regulatory issues in the US.  But back to Citigroup.

Citigroup also has acquired a 19.9% stake in an Indian brokerage firm by the name Anand Rathi Securities.  Anand Rathi provides a variety of financial services in asset management, investment banking, stock brokerage, trading, commodities, mutual funds and insurance.  It recently has been in a bidding war (against itself) over Nikko Cordial in Japan for something to the tune of $11 Billion.

What is puzzling as hell here is the Chuck Prince conundrum.  He took down a $26 million pay package last year, up from rougly $23 million the year before.  A recent homebuilder’s CEO describing the 2007 homebuilding market would describe how shareholders feel about Chuck Prince.  This stock has massively lagged, Prince Alwaleed bin Talal has called for Draconian neasures in cost cuts, I have listed him as a CEO that needs to go, media reports keeps telling him he needs to go, Cramer said he needs to go, and so on.   If his pay is GOING UP and if there is pressure being put on him to do more, then you just have to wonder what the board and what key shareholders want. 

The company has its earnings scheduled for April 16, and its annual shareholder meeting is the next day on April 17, 2007.  As earnings get closer, the CEO pressure is going to build from shareholders and from the media.  If there is another ho-hum performance and the outlook isn’t much better, then I can tell you what the shareholders will really be pushing for on April 17.  I did lay out a scenario that he could take to leave as well, so we’ll see.  Chuck Prince is also being pressured to cust costs (and maybe jobs), and if he has to cut several thousand jobs to save his own it won’t exactly make him much more popular.

Jon C. Ogg
March 23, 2007

Jon Ogg can be reached at jonogg@247wallst.com; he does not own securities in the companies he covers.

GE Short Interest Rises As Stock Stalls

The short interest in GE rose 20 million shares to 46 million in March. Maybe some clever shorts think the stock, which has been slightly down, is due to fall on the slightest hint of bad news.

Since the beginning of the year, GE (GE) shares have dropped almost 5%, while shares of rival Siemens (SI) are up over 10%. Over the last six months, the spread is even wider.

Wall St. still seem concerned that GE’s plastics business under-performs and that NBCUniversal does not belong as part of the company at all. Of course, GE’s financial operations are subject to all kinds of market forces. The sub-prime lending industry collapse does not help ease those concerns, especially since GE owns WMC Mortgage.

Douglas A. McIntyre

Europe Markets 3/23/2007

Markets in Europe were down slightly at 5.50 AM New York time.

The FTSE was off .1% to 6,313. Barclays was up .7% to 744. BT was down .6% to 306.25. BP was up 1% to 534. GSK was down .6% to 1406. Reuters was up 1% to 460.5. Vodafone was down 1% to 142.

The Daxx was down .2% to 6,840. Daimler was up 1.8% to 59.44. DB was down .8% to 99.5. DT was down 1.1% to 12.5. SAP was down 1.4% to 34.35.

The CAC 40 was down .2% to 5,580. Alcatel-Lucent was down 1.5% to 8.55. AXA was down .2% to 31.28. France Telecom was down 1.2 % to 19.92. ST Micro was up .1% to 14.3 Vivendi was up .3% to 30.08.

Data from Reuters

Douglas A. McIntyre

IPO Filing: Netezza Corp

There has been a company under the name Netezza Corporation that has filed to come public via an IPO under the ticker “NTZA” on NASDAQ.  The company lists Credit Suisse and Morgan Stanley as lead underwriters and co-managers are listed as Needham and as Thomas Weisel.  For filing purposes it lists $100 million as the amount to be raised.

The company makes performance servers called the Netezza Performance Servers  with what it feels is price consciousness, scalability, performance, power efficiency, and reliability.  As of January 31, 2007, it has shipped over 200 data warehouse appliances worldwide to 87 data-intensive customers including large global enterprises, mid-market companies and government agencies: Ahold, Amazon.com, American Red Cross, AOL, Blue Cross Blue Shield-R.I., Capital One, Catalina Marketing, CNET Networks, CompuCredit, LoanPerformance, Marriott, NASD, Neiman Marcus, Nielsen Company, Orange UK, Restoration Hardware, Ross Stores, Ryder Systems, Source Healthcare Analytics, US Army Corps of Engineers, and the US Department of Veterans Affairs.

Revenues have increased from $13.6 million in fiscal 2004 to $79.6 million in fiscal 2007.  2007 revenues are broken down as $64.6 million in product sales and $14.989 million in services.  The net loss attributable to shareholders is noted as $13.9 million for fiscal 2007.

This one is venture-backed with Matrix Partners owning 20.75%, Charles River Partnership owning 19.59%, Battery Ventures owning 16.82%, Sequoia Capital owning 15.2%, and Meritech Capital Partners holding 6.8%.  Oddly enough, Ed Zander is listed as one of the much smaller holders of the stock along with many other individuals.

In a networking and storage world-gone-wild, this one at least has a story behind it.

Jon C. Ogg
March 23, 2007

NYSE Short Interest For March

The NYSE released short interest in its stocks for the period ending March 15, 2007. The figures are compared to February 15 short interest

Largest Short Postions

Ford                  199 million

Qwest               73 million

CVS                 73 million

LSI                   72 million

CBS                 64 million

Time Warner     63 million

Halliburton        60 million

Exxon              58 milion

Pfizer               49 million

Kraft                48 million

Sprint              47 million

GM                 46 million

Weyerhsr        46 million

GE                 46 million

Disney           42 million

Largest Increases In Short Position

CBS             up 52 million

Domtar         up 42 million

Weyerhasr    up 34 million

CVS             up 22 million

Halliburton    up 21 million

GE              up 20 million

Largest Drop In Short Position

Home Depot        down 36 million

New Century       down 17 million

Duke                  down 16 million

Univision            down 15 million

Cablevision        down 8 million

Citizens Com     down 8 million

US Banc           down 8 million

Data from WSJ and NYSE

Douglas A. McInyre

Media Digest 3/23/2007

According to Reuters, Blackstone Group has filed to go public and raise $4 billion.

Reuters writes that Carlyle, the private equity company, has raised a new fund worth $15 billion.

Reuters reports that GE (GE) has plans to buy Sanyo Credit for $1.1 billion.

Reuters also reports that Citigroup (C) is considering a bid for ABN Amro.

Reuters also writes that initial bids for Chysler are expected ahead of the Daimler annual meeting on April 4.

The Wall Street Journal writes that Oracle (ORCL) accused rival SAP (SAP) of breaking into its computer system and stealing key information.

XM Radio was sued by members of the National Music Publishers Association because its sell receivers that allow listeners to store songs.

The Wall Street Journal also writes that NBC (GE) and News Corp (NWS) are launching a project to syndicate much of their key TV and film content. Distribution will be through Yahoo! (YHOO), AOL (TWX), and MSN (Microsoft).

The New York Times reports that for Motorola (MOT) to turn itself around, it needs to move away from the "hit driven" handset model and toward a long term plan with steady earnings.

The NY Times reports that Pfizer (PFE) lost a patent battle on blood pressure medication Norvasc which may allow generics to make a version of the drug.

FT reports that Morgan Stanley (MS) accouned a reorganization of most of its trading operations.

Douglas A. McIntyre